Omega-3/Omega-6 Supplement Formula Slows Parkinson’s Symptom Progression in Small Trial
This study tested a nutritional formula called Neuroaspis PLP10, made up of high doses of omega-3 fats (EPA and DHA) and omega-6 fats (GLA and linoleic acid), along with vitamin A, vitamin E, and a concentrated form of gamma-tocopherol (an antioxidant related to vitamin E).
Forty people with early Parkinson’s disease were randomly assigned to take either this formula or a placebo (olive oil) daily for 30 months, in addition to their usual Parkinson’s medications. Researchers tracked disease progression using two standard scales used by neurologists.
By the end of the study, the group taking the omega-3/omega-6/antioxidant formula showed significantly less worsening on the UPDRS III motor symptom scale compared to the placebo group. The authors describe this as a potential delay in disease progression when the formula was used alongside conventional treatment.
What this means for you
This small, long-term trial suggests that a specific combination of omega-3s, omega-6s, and antioxidant vitamins may be worth further study as a companion to standard Parkinson’s care, but with only 40 participants, larger trials are needed before drawing firm conclusions.
Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.
Start the ALP ProtocolSource
Clinical neurology and neurosurgery · 2021-11-01 · DOI: 10.1016/j.clineuro.2021.106954
Read the original source ↗This summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.